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Herpes simplex virus type 1 (HSV-1) is frequently isolated from the respiratory tract of criti-
cally ill patients. However, diagnosis of clinically significant HSV-1 pneumonia is difficult as
the presentation is non-specific and there is no diagnostic reference standard to differentiate
from non-infectious contamination.
We present a case of HSV-1 pneumonia in a young asthmatic patient who was potentially
immunocompromised through long-term corticosteroid usage. The quantitative PCR titre from
bronchoalveolar lavage fluid was high (9 103 copies/ml) and the patient made a dramatic
clinical and radiographic recovery upon treatment with acyclovir. We suggest that similar
PCR levels in the appropriate clinical setting should prompt consideration of anti-viral therapy.
ª 2008 Elsevier Ltd. All rights reserved.Case report
A 39 year old female presented to the emergency depart-
ment with a 3-week history of dyspnoea and cough
productive of green sputum. She had a history of asthma
since childhood, complicated by ongoing cigarette smoking,
poor compliance with medication, obesity and recurrent
lower respiratory tract infections. During the six months
prior to her admission she had been treated with numerous. James’s Hospital, Dublin,
unbury Court, Dartry, Dublin
x: þ0035314103549.
(M. Pallin).
ll rights reserved.courses of antibiotics and received oral corticosteroids on
an almost continuous basis.
On physical examination she was cyanosed and tachyp-
noeic but afebrile and haemodynamically stable. Chest
auscultation revealed bilateral inspiratory and expiratory
wheeze with poor breath sounds. Blood tests showed
a normal white cell count but slightly reduced lymphocyte
count at 0.5 109/L. Arterial blood gas analysis demon-
strated hypoxia. The C-reactive protein was elevated at
292 mg/L. Coagulation and biochemistry studies were
otherwise normal. Subsequent sputum and blood cultures
and atypical pneumonia screen were clear. Chest X-Ray
demonstrated diffuse fine bilateral pulmonary infiltrates
(Fig. 1). Computed tomography (CT) of thorax demon-
strated bilateral diffuse ground glass infiltrates,
Figure 1 Chest X-Ray on initial presentation.
Figure 2 Computed tomography of thorax; sections from (a)
upper and (b) lower lobes.
100 M. Pallin et al.predominantly in the upper lobes without evidence of
interstitial fibrosis (Fig. 2a and b).
She was admitted to the intensive therapy unit (ITU) and
treated with broad spectrum antibiotics, antifungal therapy
and corticosteroids. However, she continued to deteriorate
and required intubation, ventilation and inotropic support.
Bronchoscopy was normal and bronchoalveolar lavage (BAL)
fluid was sent for viral, fungal and bacterial culture. In
addition, a video-assisted thoracoscopic lung biopsy was
performed, histological examination of which revealed non-
specific diffuse alveolar damage only. However, quantita-
tive PCR of BAL fluid revealed a HSV-1 PCR titre of
9 103 copies/ml. In addition, a serum sample collected at
the same time was positive for HSV-1 by realtime PCR at
1 103 copies/ml. HSV-1 was isolated eventually from BAL.
No other micro-organism was identified. A diagnosis of HSV-
1 pneumonia was suspected and therapy was commenced
with intravenous Acyclovir. Within 24 h there was a marked
clinical improvement and several days later she was
weaned from mechanical ventilation and discharged to the
ward. A repeat CT scan prior to her discharge showed
clearing of her bilateral infiltrates (Fig. 3).
Discussion
HSV-1 pneumonia is well documented in immunocompro-
mised patients. Burns, solid organ and haemopoietic stem
cell transplant, malignancy, pregnancy, HIV infection, and
immunosuppressive drug therapy have all been associa-
ted.1e5 However, in the immunocompetent, confirmed
pulmonary infection is rare6 and the clinical relevance and
pathogenicity of the virus, although frequently isolated
from the lungs of critically ill ventilated patients,7 is
uncertain. HSV-1 contamination of the lower respiratory
tract may occur by spread or aspiration from oropharyngeal
lesions that may be facilitated by endotracheal intubation.
It is often unclear, therefore, whether HSV-1 isolation
represents infection or is merely a side manifestation ofsevere lung disease and/or immunocompromise with
contamination by reactivated virus. Although some inves-
tigators have demonstrated that HSV-1 isolation from the
lungs of such patients is associated with a poorer outcome
and increased mortality,8e10 others have not.11
Clinical differentiation between HSV-1 infection and
other cause of pneumonia is unreliable; the symptoms are
non-specific, as are the typical radiographic findings that
include scattered multi-focal segmental and subsegmental
ground glass opacities, focal areas of consolidation and
pleural effusions.12
In the laboratory a diagnostic reference standard to
differentiate clinically relevant HSV lung infection from non-
infectious contamination is lacking.6 Detection of HSV-1, in
bronchial lavage or biopsy samples, may be achieved by viral
culture, serology, PCR or demonstration of HSV-specific
Figure 3 Computed tomography of thorax after treatment
with acyclovir.
Pneumonia failing to respond to treatment 101cellular nuclear inclusions. Lung biopsy has been shown to be
unreliable and has failed to demonstrate evidence of viral
infection despite isolation of the virus from lung tissue at
autopsy.13 More recently, quantitative PCR has shown
promise by demonstrating an association between viral load
and mortality that may guide treatment.14
In our patient a diagnosis of HSV-1 pneumonitis was
made based on a quantitative BAL PCR finding of
9 103 copies/ml, with clinical and radiological evidence
of pneumonia on a background of potential immunocom-
promise due to long-term steroid use. Treatment with
intravenous acyclovir, when multiple other therapies had
failed, was associated with a dramatic clinical and radio-
logical improvement. We suggest that a similar HSV-1 PCR
titre in the appropriate clinical setting should prompt
consideration of anti-viral therapy at least until future
studies better define a reference range.Conflict of interest statement
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